Stay updated with breaking news from Quantum Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Update of Shareholding Situation Following April 27, 2022 Capital Raise Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a
Quantum Genomics announces successful capital raising with a gross sum of approximately €15.6 M€ Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat
Quantum Genomics Raises a Gross Amount of Approximately € 15 M Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription
/PRNewswire/ -- DelveInsight's Treatment-resistant Hypertension Market Insights report includes a comprehensive understanding of current treatment practices,...
DelveInsight's analysts estimate that the Treatment-resistant Hypertension market is expected to show positive growth, mainly attributed to increased prevalence and the anticipated launch of